ARTICLE | Clinical News
Enzon, Santaris preclinical data
March 30, 2009 7:00 AM UTC
EZN-4187 dose-dependently reduced androgen receptor mRNA by up to 80% in the liver in vivo. The androgen receptor locked nucleic acid (LNA) antisense oligonucleotide (LNA-ON) also significantly reduc...